Digital Pathology News

Discussion with CEOs from Inspirata and Omnyx

| February 14, 2018 | 0 Comments

In the wake of the news of Inspirata acquiring Omnyx recently I had an opportunity to speak with the CEOs of each company and get their thoughts. The big question in my mind and those of many readers was “Why Omnyx? Why now?” How did this happen? Below is a summary of our discussion. Perhaps […]

Continue Reading

Paige.AI Lands $25 Million Series A Financing and 25 Million Slides from Memorial Sloan Kettering

| February 8, 2018 | 0 Comments

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), recently announced two major milestones: Paige.AI signed a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain […]

Continue Reading

Mass Validation Study of OptraSCAN Digital Pathology Leads to Approval by Government of India

| February 7, 2018 | 0 Comments

Largest digital pathology study to date, analyzing and validating over 6600 FFPE slides, yields an approval for the use of OptraSCAN® whole slide scanners in India medical settings SUNNYVALE, CA–(BUSINESS WIRE)—OptraSCAN today announced it has successfully completed the mass validation of its whole slide digital scanner OptraSCAN® with the support of India’s Biotechnology Industry Research […]

Continue Reading

So, is the mass 17 cm or 1.7 cm?

| February 4, 2018 | 0 Comments

One of my favorite YouTube videos is entitled “Surgeon vs. Pathologist” but it could easily be “Pulmonologist” or “Gastroenterologist” or “Urologist” or more “vs. Pathologist”. Every pathologist has their own stories about these incidences and cases. The one below really happened to me years ago (parts of it are intermixed with some details of other […]

Continue Reading

Pathology News

Discussion with CEOs from Inspirata and Omnyx

| February 14, 2018 | 0 Comments

In the wake of the news of Inspirata acquiring Omnyx recently I had an opportunity to speak with the CEOs of each company and get their thoughts. The big question in my mind and those of many readers was “Why Omnyx? Why now?” How did this happen? Below is a summary of our discussion. Perhaps […]

Continue Reading

Paige.AI Lands $25 Million Series A Financing and 25 Million Slides from Memorial Sloan Kettering

| February 8, 2018 | 0 Comments

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), recently announced two major milestones: Paige.AI signed a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain […]

Continue Reading

Mass Validation Study of OptraSCAN Digital Pathology Leads to Approval by Government of India

| February 7, 2018 | 0 Comments

Largest digital pathology study to date, analyzing and validating over 6600 FFPE slides, yields an approval for the use of OptraSCAN® whole slide scanners in India medical settings SUNNYVALE, CA–(BUSINESS WIRE)—OptraSCAN today announced it has successfully completed the mass validation of its whole slide digital scanner OptraSCAN® with the support of India’s Biotechnology Industry Research […]

Continue Reading

So, is the mass 17 cm or 1.7 cm?

| February 4, 2018 | 0 Comments

One of my favorite YouTube videos is entitled “Surgeon vs. Pathologist” but it could easily be “Pulmonologist” or “Gastroenterologist” or “Urologist” or more “vs. Pathologist”. Every pathologist has their own stories about these incidences and cases. The one below really happened to me years ago (parts of it are intermixed with some details of other […]

Continue Reading

Education

Paige.AI Lands $25 Million Series A Financing and 25 Million Slides from Memorial Sloan Kettering

| February 8, 2018 | 0 Comments

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), recently announced two major milestones: Paige.AI signed a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain […]

Continue Reading

So, is the mass 17 cm or 1.7 cm?

| February 4, 2018 | 0 Comments

One of my favorite YouTube videos is entitled “Surgeon vs. Pathologist” but it could easily be “Pulmonologist” or “Gastroenterologist” or “Urologist” or more “vs. Pathologist”. Every pathologist has their own stories about these incidences and cases. The one below really happened to me years ago (parts of it are intermixed with some details of other […]

Continue Reading

The Barber Shop

| January 28, 2018 | 0 Comments

Until I was about 5, my family and I lived above my father’s photography studio along a busy road in a near Western suburb of Chicago. Much like Cicero, that I mentioned a year ago about The Knife Sharpener and Jimmy, unless you lived or worked in Berwyn, there was little reason for you to […]

Continue Reading

He Signs Out By Telepathology While on a Motorcycle – The Most Interesting Pathologist in the World

| January 25, 2018 | 0 Comments

From the very talented DRdoubleB comes another series of videos on YouTube highlighting The Most Interesting Pathologist in the World. This pathologist has us all beat – he definitely is The Most Interesting Pathologist in the World. Who else can sign out cases on their motorcycle by telepathology? Or make tumors differentiate? Who else can […]

Continue Reading

Medical Research

Paige.AI Lands $25 Million Series A Financing and 25 Million Slides from Memorial Sloan Kettering

| February 8, 2018 | 0 Comments

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), recently announced two major milestones: Paige.AI signed a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain […]

Continue Reading

Techcyte and Motic Partner to Provide a Next Generation Digital Pathology Solution

| January 23, 2018 | 0 Comments

Deep machine learning platform and world-class scanning hardware combine for a complete digital pathology solution for veterinary, human and air quality labs OREM, Utah – Techcyte Inc., a provider of deep learning image analysis solutions, and Motic, a leading provider of whole slide scanners, today announced the two companies will be cooperating to provide advanced solutions […]

Continue Reading

Histoindex’s Stain-Free Digital Pathology System Receives HSA Approval for Liver Diagnosis

| January 12, 2018 | 0 Comments

Designed to aid pathologists in the clinical diagnosis of liver fibrosis and other chronic liver diseases, the stain-free Laennec® digital pathology imaging system by MedTech innovator Histoindex Pte. Ltd. has achieved its first regulated in vitro diagnostics (IVD) product status with the issuance of a Health Sciences Authority (HSA) Class A licence. This is a world’s first achievement for a […]

Continue Reading

Digital Pathology Advancing Medicine to the Digital Age – Part of the 25th Annual Molecular Medicine Tri-Conference

| December 6, 2017 | 0 Comments

February 12-14, 2018   |   Moscone South Convention Center   |   San Francisco, CA Triconference.com/Digital-Pathology Bristol-Myers Squibb and Genentech to Present on Benefits of Multiplex Immunohistochemistry at CHI’s Digital Pathology Conference in San Francisco Multiplexes IHC and Image Analysis in Immuno-Oncology Drug Development and Companion Diagnostics Michael C. Montalto, Ph.D., Executive Director, Translational Medicine, Bristol-Myers Squibb Conventional immunohistochemistry, […]

Continue Reading

Anatomic Pathology

Discussion with CEOs from Inspirata and Omnyx

| February 14, 2018 | 0 Comments

In the wake of the news of Inspirata acquiring Omnyx recently I had an opportunity to speak with the CEOs of each company and get their thoughts. The big question in my mind and those of many readers was “Why Omnyx? Why now?” How did this happen? Below is a summary of our discussion. Perhaps […]

Continue Reading

Paige.AI Lands $25 Million Series A Financing and 25 Million Slides from Memorial Sloan Kettering

| February 8, 2018 | 0 Comments

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), recently announced two major milestones: Paige.AI signed a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain […]

Continue Reading

So, is the mass 17 cm or 1.7 cm?

| February 4, 2018 | 0 Comments

One of my favorite YouTube videos is entitled “Surgeon vs. Pathologist” but it could easily be “Pulmonologist” or “Gastroenterologist” or “Urologist” or more “vs. Pathologist”. Every pathologist has their own stories about these incidences and cases. The one below really happened to me years ago (parts of it are intermixed with some details of other […]

Continue Reading

Inspirata Acquires Omnyx

| January 31, 2018 | 0 Comments

News today from two of the biggest names in digital pathology. In the past six years or so we have seen Roche acquire BioImagene, Aperio get acquired by Leica Biosystems and Philips acquire PathXL. Two of those being examples of large international IVD companies purchasing primarily scanner companies (I realize they both had some workflow […]

Continue Reading

Business

Discussion with CEOs from Inspirata and Omnyx

| February 14, 2018 | 0 Comments

In the wake of the news of Inspirata acquiring Omnyx recently I had an opportunity to speak with the CEOs of each company and get their thoughts. The big question in my mind and those of many readers was “Why Omnyx? Why now?” How did this happen? Below is a summary of our discussion. Perhaps […]

Continue Reading

Inspirata Acquires Omnyx

| January 31, 2018 | 0 Comments

News today from two of the biggest names in digital pathology. In the past six years or so we have seen Roche acquire BioImagene, Aperio get acquired by Leica Biosystems and Philips acquire PathXL. Two of those being examples of large international IVD companies purchasing primarily scanner companies (I realize they both had some workflow […]

Continue Reading

Inspirata Acquires Toronto-based Artificial Intelligence In Medicine, Inc. (AIM) to Enhance its R&D in Artificial Intelligence and Natural Language Processing

| January 3, 2018 | 0 Comments

The strategic acquisition enhances Inspirata’s R&D capability in Artificial Intelligence and Natural Language Processing, enabling it to offer its clients advanced capabilities to extract cancer data from narrative text in clinical documents for better data analysis and reporting. Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced yesterday that it has acquired Toronto-based […]

Continue Reading

XIFIN Taps FrontRunnerHC for Integrated Insurance Detection Within RPM 9 to Help Labs Maximize Reimbursement

| December 18, 2017 | 0 Comments

Best-of-breed solution and real-time integration drives return on investment for XIFIN RPM 9 customers seeking greater revenues and workflow efficiencies; average FrontRunnerHC customers realize nearly 40% increase in coverage discovery XIFIN, Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, recently announced the company has teamed with FrontRunnerHC and integrated its PatientRemedi insurance discovery […]

Continue Reading

Other Recent Articles

Digital Pathology Extending Through UK as OptraSCAN Welcomes First On-Demand UK Customer

| January 24, 2018 | 0 Comments

NHS Trust Plymouth Hospitals, Derriford Hospital, implements On-Demand Digital Pathology® for research and training, as the adoption of digital pathology workflows increases OptraSCAN today announced its first UK-based customer NHS Trust Plymouth Hospital, Derriford. Derriford Hospital plans to utilize digital pathology for routine research and training of professionals in the field of pathology and digital […]

Continue Reading

American Association of Anatomists Launches Virtual Microscopy Database Powered by Biolucida®

| January 19, 2018 | 0 Comments

Free resource for educators and researchers features thousands of downloadable histology slides Educators and researchers around the world now have free access to a database of whole slide images (also known as virtual slides) for histology and pathology. Featuring thousands of virtual slides contributed by 15 universities, The Virtual Microscopy Database, VMD, (http://www.virtualmicroscopydatabase.org) is an […]

Continue Reading

Huron Digital Pathology Receives ISO 13485 Certification for Medical Device Quality Management

| January 17, 2018 | 0 Comments

Congratulations to Huron Digital Pathology on this certification! Waterloo, Ontario, Canada – January 17, 2018 – Huron Digital Pathology announced today that it has earned ISO 13485:2003 certification from SAI Global. This certification indicates that the company’s quality management system complies with the requirements of ISO 13485:2003 for the design, manufacture, installation and servicing of […]

Continue Reading

HalioDx closed a Series B round of €18.5 million (US$22.3 million)

| January 17, 2018 | 0 Comments

This funding will accelerate the development of Immunoscore® in selected cancers, and support set up of commercial activities in the US This round was led by PSIM fund managed by Bpifrance in the framework of the program ‘Investing for the Future’ Marseille, France, January 17, 2018 – HalioDx, a diagnostic company expert in the analysis […]

Continue Reading

Flagship Biosciences ActionAssays Deliver Actionable Data to Drive Immuno-Oncology Decisions

| January 16, 2018 | 0 Comments

Flagship Biosciences has introduced a new menu of services to help drug developers more confidently define their path to success. ActionAssays is a comprehensive catalog of brightfield immunohistochemistry (IHC) assays that provide actionable data to define and advance biomarker programs. Flagship Biosciences has introduced a new menu of services to help drug developers more confidently […]

Continue Reading

NovoPath™ Anatomic Pathology Software System Integrates with Philips IntelliSite Pathology Solution and Wholeslide Imaging System

| January 10, 2018 | 0 Comments

NovoPath, Inc. announces the integration of the NovoPathTM Anatomic Pathology Software Platform with Philips IntelliSite Pathology Solution and Wholeslide Imaging System. This announcement follows a thorough process of development and testing to integrate anatomic pathology (AP) workflows between Philips IntelliSite Image Management System and NovoPath’s Anatomic Pathology LIS software at a major client that employs both technologies. “Using […]

Continue Reading

Norton

| January 7, 2018 | 0 Comments

Norton was a tall, thin, African-American gentlemen with short-cropped hair that was mostly gray with black highlights. He spoke softly with a rich vocabulary. He would have been in his mid-late 60’s when I first met him and worked with him. You could say he looked like Morgan Freeman but taller. He never married and […]

Continue Reading

Corista Wins 2017 Award for Most Promising Workflow Solution Provider

| January 5, 2018 | 0 Comments

 Corista, an integrated pathology solutions leader, received the “20 Most Promising Workflow Solution Providers 2017” award from CIOReview, an annual listing of the top solution providers that help organizations manage their complicated business processes. “We are delighted to be on CIOReview’s list of top workflow solution providers,” Corista Founder, President and CEO Elizabeth Wingard said. […]

Continue Reading

Announcement: National Society for Histotechnology Digital Pathology Certificate of Completion Coming Soon

| January 5, 2018 | 0 Comments

The NSH Digital Pathology Certificate Program, in collaboration with the Digital Pathology Association, is scheduled to be available for purchase on learn.nsh.org in April 2018. If you have questions about the course please reach out to NSH Director of Meetings & Education, Aubrey Wanner, aubrey@nsh.org. Source: National Society for Histotechnology  

Continue Reading

The Cost of Information

| January 1, 2018 | 0 Comments

Reluctantly, my father (and occasionally my mother) would stop at a gas station to ask for directions. Not the kind of gas stations with hotdogs and coolers of beer. The kind that offered “full service”, checking your oil and windshield wiper fluid and without more than a few packs of gum or peanuts, if that. […]

Continue Reading

Are you claustrophobic Mr. Kaplan? A fine line between safety and indolence

| December 26, 2017 | 0 Comments

  As part of my ongoing evaluation and treatment for heart failure that I have mentioned previously (see: http://tissuepathology.com/2017/11/05/the-clinic-door-chapter-2-the-emergency-room/#axzz52Q1JZUgB) I underwent a cardiac MRI recently. Prior to scheduling the MRI, I was asked about pacemakers, defibrillators and artificial joints or shrapnel in my medical history. I was told to show up 30 minutes prior to […]

Continue Reading

Leica Biosystems to Advance Artificial Intelligence in Pathology as part of UK Life Sciences Sector Deal

| December 21, 2017 | 0 Comments

The United Kingdom continues adoption of digital pathology including this latest news between Leica Biosystems and the UK government in Leica’s latest announcement of leveraging artificial intelligence through the UK Office of Life Sciences.  Newcastle, UK, Dec 21, 2017 – A transformative sector deal was announced between companies of the UK life sciences sector and […]

Continue Reading